Billion
Novartis Partners with Dren Bio in $3 Billion Deal for Targeted Myeloid Engagers
Novartis, Dren Bio, Myeloid Engagers, Biotech, Pharmaceutical, Alliance, $3 Billion Deal
Ipsen Licenses Second ADC via $1B Bet on Foreseen Bio Asset
Ipsen, Foreseen Biotechnology, Antibody-Drug Conjugate (ADC), Licensing Agreement, $1 Billion Deal
Sanofi Seeks Private Equity Bids for $20 Billion Consumer Health Division
Sanofi, Consumer Health, Private Equity, Bids, $20 Billion